Biotech Currents
Subscribe
Sign in
Share this post
Biotech Currents
MoonLake's (MLTX) phase III data in Vela trials could kickstart skin disease franchise
Copy link
Facebook
Email
Notes
More
MoonLake's (MLTX) phase III data in Vela…
Bill Langbein
May 21
Share this post
Biotech Currents
MoonLake's (MLTX) phase III data in Vela trials could kickstart skin disease franchise
Copy link
Facebook
Email
Notes
More
Assigning a 68.2% overall probability MoonLake will report positive data from the Vela trials.
Read →
Comments
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
MoonLake's (MLTX) phase III data in Vela…
Share this post
Assigning a 68.2% overall probability MoonLake will report positive data from the Vela trials.